Meteora Capital’s Verona Pharma VRNA Stock Holding History

Meteora Capital’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-40,000	Closed	-$4.27M	–	438
2025 Q3	$4.27M	Buy	+40,000	New	+$4.18M	0.45%	61

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Meteora Capital's VRNA Position: Q4 2025 in Review

Meteora Capital sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 40,000 shares — an estimated $4.27M sold.

Meteora Capital first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $4.27M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Meteora Capital reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Meteora Capital sold 40,000 Verona Pharma shares in Q4 2025, an estimated $4.27M.
Meteora Capital first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Meteora Capital's Verona Pharma position peaked at $4.27M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Meteora Capital's 13F filing for Q4 2025, filed 17 Feb 2026.